It has been known for years that SMYD3 overexpression is related to transcriptional changes in cancer cells (2,11,12,39), but it is only recently that molecular studies have merged to elucidate the oncogenic actions of this chromatin regulator. This evidence concerns the gene SMYD3 and cancer.